HIGHLIGHTS
- who: Guozeng Xu from the Yuhuangding Hospital and Red Cross HospitalTheVrije Brussel, Belgium of Catanzaro, Italy have published the article: The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer, in the Journal: (JOURNAL) of December/31,/2015
- what: The authors evaluated the infiltration of macrophages marked with CD86 and CD163 in tumor tissues by the immunohistochemistry technique and focused on CD86/ CD163 ratio, according to the STROBE guidelines . The authors aimed to provide enough evidence for the recurrence-risk stratification of stage II-III CRC. The study demonstrated that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.